February 25, 2013 at 07:36 AM EST
China Grand Pharma Forms JV with HuangShi Feiyun Pharma
China Grand Pharmaceutical and Healthcare will form a JV with HuangShi Feiyun Pharma that will be capitalized with $20 million. China Grand Pharma will contribute $12 million while HuangShi Feiyun will purchase the remaining 40% with $8 million. HuangShi Feiyun is an oncology drug and anti-viral medicines company located in Hubei Province. Its products will be the basis of the new JV and will serve to expand China Grand Pharma’s portfolio. More details.... Stock Symbol: (HK: 00512) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here